Exodus Point Capital Management, LP Revolution Medicines, Inc. Transaction History

Exodus Point Capital Management, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$25.17 - $35.05 $3.83 Million - $5.34 Million	152,290 New	152,290 $4.22 Million
Q3 2022 Nov 10, 2022	SELL	$17.46 - $26.0 $1,571 - $2,340	-90 Reduced 0.23%	38,676 $763,000
Q2 2022 Aug 19, 2022	BUY	$14.54 - $27.17 $241,058 - $450,451	16,579 Added 74.72%	38,766 $756,000
Q1 2022 May 13, 2022	BUY	$17.31 - $26.4 $207,044 - $315,770	11,961 Added 116.97%	22,187 $566,000
Q4 2021 Feb 11, 2022	BUY	$24.35 - $33.7 $249,003 - $344,616	10,226 New	10,226 $257,000
Q2 2021 Aug 16, 2021	SELL	$29.0 - $47.44 $251,198 - $410,925	-8,662 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$37.21 - $54.43 $192,450 - $281,511	-5,172 Reduced 37.39%	8,662 $397,000
Q4 2020 Feb 16, 2021	BUY	$30.19 - $45.49 $417,648 - $629,308	13,834 New	13,834 $548,000

266

161M

260K

620K

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.8B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.